• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer.

作者信息

Glehen O, Chapet O, Adham M, Nemoz J C, Gerard J P

机构信息

Department of Surgery, Centre Hospitalier Lyon-Sud, Lyons, France.

出版信息

Br J Surg. 2003 Aug;90(8):996-8. doi: 10.1002/bjs.4162.

DOI:10.1002/bjs.4162
PMID:12905554
Abstract
摘要

相似文献

1
Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer.里昂R90-01术前放疗延迟手术随机试验的长期结果及其对直肠癌保肛手术的影响。
Br J Surg. 2003 Aug;90(8):996-8. doi: 10.1002/bjs.4162.
2
Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function.术前大剂量放疗后经腹经肛门切除远端直肠癌：中国保留括约肌功能的经验
Isr Med Assoc J. 2006 Oct;8(10):675-8.
3
Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.瑞典直肠癌试验：放疗对生存率和局部复发率有长期益处。
J Clin Oncol. 2005 Aug 20;23(24):5644-50. doi: 10.1200/JCO.2005.08.144.
4
Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.低位直肠癌的术前放化疗。对降期及保肛手术的影响。
Hepatogastroenterology. 2004 Nov-Dec;51(60):1703-7.
5
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.医院手术量对高危根治性切除直肠癌手术操作及长期预后的影响：来自Intergroup 0114研究的结果
J Clin Oncol. 2004 Jan 1;22(1):166-74. doi: 10.1200/JCO.2004.04.172.
6
The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.TME试验，中位随访6年：可切除直肠癌放疗患者的局部控制率提高，但无生存获益。
Ann Surg. 2007 Nov;246(5):693-701. doi: 10.1097/01.sla.0000257358.56863.ce.
7
Preoperative radiotherapy improves outcome in recurrent rectal cancer.术前放疗可改善复发性直肠癌的治疗效果。
Dis Colon Rectum. 2005 May;48(5):918-28. doi: 10.1007/s10350-004-0891-6.
8
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.一项比较术前短程放疗与术前常规分割放化疗治疗直肠癌的随机试验的长期结果
Br J Surg. 2006 Oct;93(10):1215-23. doi: 10.1002/bjs.5506.
9
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.直肠癌术前放疗后括约肌保留：一项比较短期放疗与常规分割放化疗的随机试验报告
Radiother Oncol. 2004 Jul;72(1):15-24. doi: 10.1016/j.radonc.2003.12.006.
10
[Influence of preoperative (hyperthermic) radiochemotherapy on manometric anal sphincter function in locally advanced rectal cancer].[术前（热疗）放化疗对局部晚期直肠癌肛门括约肌测压功能的影响]
Strahlenther Onkol. 2004 May;180(5):281-8. doi: 10.1007/s00066-004-1173-x.

引用本文的文献

1
Which is the best timing to assess response after chemoradiation in locally advanced cervical cancer (BRILACC)?局部晚期宫颈癌放化疗后评估反应的最佳时机是什么（BRILACC研究）？
Strahlenther Onkol. 2025 Sep 12. doi: 10.1007/s00066-025-02463-3.
2
Pathologic Complete Response and Survival in Rectal Cancer: A Systematic Review and Meta-Analysis.直肠癌的病理完全缓解与生存：一项系统评价和荟萃分析
JAMA Netw Open. 2025 Jul 1;8(7):e2521197. doi: 10.1001/jamanetworkopen.2025.21197.
3
A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma.
预测直肠腺癌病理完全缓解的模型。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231202893. doi: 10.1177/15330338231202893.
4
Optimal waiting period to surgical treatment after neoadjuvant chemoradiotherapy for locally advanced rectum cancer: a retrospective observational study.新辅助放化疗后局部进展期直肠癌手术治疗的最佳等待时间：一项回顾性观察研究。
Langenbecks Arch Surg. 2023 May 25;408(1):210. doi: 10.1007/s00423-023-02930-4.
5
The Impact of Narrow and Infiltrated Distal Margin After Proctectomy for Rectal Cancer on Patients' Outcomes: a Systematic Review and Meta-analysis.直肠癌直肠切除术后狭窄及浸润性远切缘对患者预后的影响：一项系统评价和Meta分析
Indian J Surg Oncol. 2022 Dec;13(4):750-760. doi: 10.1007/s13193-022-01565-z. Epub 2022 Jun 16.
6
Effect of interval between neoadjuvant chemoradiotherapy and surgery on disease recurrence and survival in rectal cancer: long-term results of a randomized clinical trial.新辅助放化疗与手术间隔时间对直肠癌复发和生存的影响：一项随机临床试验的长期结果。
BJS Open. 2022 Sep 2;6(5). doi: 10.1093/bjsopen/zrac107.
7
Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer.免疫检查点抑制作为局部晚期直肠癌新辅助治疗的一种策略
J Immunother Precis Oncol. 2021 Mar 26;4(2):86-104. doi: 10.36401/JIPO-20-31. eCollection 2021 May.
8
Factors Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: The Experience of a Single Institution with 269 Patients (STONE-01).预测直肠癌新辅助放化疗病理反应的因素：一家机构对269例患者的经验（STONE-01）
Cancers (Basel). 2021 Dec 2;13(23):6074. doi: 10.3390/cancers13236074.
9
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).度伐鲁单抗（MEDI 4736）联合延长新辅助方案治疗直肠癌的随机 II 期研究（PRIME-RT）方案。
Radiat Oncol. 2021 Aug 26;16(1):163. doi: 10.1186/s13014-021-01888-1.
10
Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm.局部晚期直肠癌的个性化治疗：将病理、分子遗传和免疫生物标志物纳入多模式治疗模式
Front Oncol. 2020 Aug 14;10:1369. doi: 10.3389/fonc.2020.01369. eCollection 2020.